Retour
46
Fourchette du Jour
73,89 €
76,09 €
Fourchette 52 Semaines
62,77 €
93,50 €
Volume
88 526
Moyenne 50J / 200J
83,01 €
/
80,91 €
Clôture Précédente
74,70 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 75,7 | 0,3 |
| P/B | 2,4 | 3,0 |
| ROE % | 3,1 | 3,7 |
| Net Margin % | 1,9 | 3,8 |
| Rev Growth 5Y % | 12,1 | 10,0 |
| D/E | 0,9 | 0,2 |
Objectif de Cours des Analystes
Hold
102,00 €
+36.1%
P/E Prévisionnel
26,05
BPA Prévisionnel
2,88 €
Croissance BPA (est.)
+0,0%
CA Est.
838,76M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
3,88 €
3,78 € – 4,02 €
|
984,55M | 1 |
| FY2027 |
3,31 €
3,07 € – 3,68 €
|
885,12M | 5 |
| FY2026 |
2,88 €
2,68 € – 3,19 €
|
838,76M | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | 0,68 € | 0,67 € | -0,7% |
| 2025-11-05 | 0,67 € | 0,66 € | -1,5% |
| 2025-08-06 | 0,71 € | 0,81 € | +14,1% |
| 2025-05-07 | 0,46 € | 0,48 € | +4,3% |
| 2025-02-26 | 0,69 € | 0,65 € | -5,8% |
| 2024-11-05 | 0,68 € | 0,69 € | +1,5% |
| 2024-08-13 | 0,81 € | 0,73 € | -9,9% |
| 2024-05-07 | 0,56 € | 0,51 € | -8,9% |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
1,82%
Growth (3Y)
3,15%
Growth (5Y)
41,26%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 13, 2026 | Apr 10, 2026 | 0,46 € | 2,36% |
| Nov 17, 2025 | Dec 12, 2025 | 0,45 € | 2,57% |
| Aug 22, 2025 | Sep 12, 2025 | 0,45 € | 2,05% |
| May 23, 2025 | Jun 13, 2025 | 0,45 € | 2,41% |
| Mar 14, 2025 | Apr 11, 2025 | 0,45 € | 2,31% |
| Nov 15, 2024 | Dec 06, 2024 | 0,44 € | 1,96% |
| Aug 23, 2024 | Sep 13, 2024 | 0,44 € | 2,06% |
| May 22, 2024 | Jun 14, 2024 | 0,44 € | 1,69% |
| Mar 11, 2024 | Apr 05, 2024 | 0,44 € | 1,63% |
| Nov 15, 2023 | Dec 08, 2023 | 0,43 € | 1,98% |
| Aug 17, 2023 | Sep 08, 2023 | 0,43 € | 1,67% |
| May 17, 2023 | Jun 09, 2023 | 0,43 € | 1,50% |
| Mar 09, 2023 | Apr 07, 2023 | 0,43 € | 1,75% |
| Nov 18, 2022 | Dec 16, 2022 | 0,41 € | 1,91% |
| Aug 17, 2022 | Sep 16, 2022 | 0,41 € | 1,93% |
| May 13, 2022 | Jun 14, 2022 | 0,41 € | 1,51% |
| Mar 11, 2022 | Apr 08, 2022 | 0,41 € | 1,61% |
| Nov 12, 2021 | Dec 10, 2021 | 0,38 € | 1,46% |
| Aug 19, 2021 | Sep 17, 2021 | 0,38 € | 1,00% |
| May 13, 2021 | Jun 11, 2021 | 0,35 € | 0,60% |
Points Clés
Revenue grew 12,07% annually over 5 years — strong growth
Earnings declined -43,08% over the past year
ROE of 3,12% is below average
Generating 60,99M in free cash flow
P/E of 75,67 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,26%
Croissance
Revenue Growth (5Y)
12,07%
Revenue (1Y)16,33%
Earnings (1Y)-43,08%
FCF Growth (3Y)-8,40%
Qualité
Return on Equity
3,12%
ROIC6,69%
Net Margin1,93%
Op. Margin10,30%
Sécurité
Debt / Equity
0,89
Current Ratio1,01
Interest Coverage8,50
Valorisation
P/E Ratio
75,67
Forward P/E26,14
P/B Ratio2,39
EV/EBITDA19,02
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,33% | Revenue Growth (3Y) | 13,64% |
| Earnings Growth (1Y) | -43,08% | Earnings Growth (3Y) | 1,31% |
| Revenue Growth (5Y) | 12,07% | Earnings Growth (5Y) | -14,22% |
| Profitability | |||
| Revenue (TTM) | 780,99M | Net Income (TTM) | 15,06M |
| ROE | 3,12% | ROA | 1,25% |
| Gross Margin | 20,15% | Operating Margin | 10,30% |
| Net Margin | 1,93% | Free Cash Flow (TTM) | 60,99M |
| ROIC | 6,69% | FCF Growth (3Y) | -8,40% |
| Safety | |||
| Debt / Equity | 0,89 | Current Ratio | 1,01 |
| Interest Coverage | 8,50 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 1,82% |
| Dividend Growth (3Y) | 3,15% | Dividend Growth (5Y) | 41,26% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 75,67 | Forward P/E | 26,14 |
| P/B Ratio | 2,39 | P/S Ratio | 1,46 |
| PEG Ratio | -3,45 | Forward PEG | N/A |
| EV/EBITDA | 19,02 | Fwd EV/EBITDA | 12,96 |
| Forward P/S | 1,36 | Fwd Earnings Yield | 3,83% |
| FCF Yield | 5,35% | ||
| Market Cap | 1,14B | Enterprise Value | 1,53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 780,99M | 671,35M | 604,80M | 553,14M | 495,02M |
| Net Income | 15,06M | 26,46M | 14,67M | 28,27M | 27,82M |
| EPS (Diluted) | 1,42 | 1,84 | 1,28 | 3,34 | 4,49 |
| Gross Profit | 157,34M | 123,92M | 121,51M | 112,02M | 117,18M |
| Operating Income | 80,43M | 63,21M | 52,06M | 56,80M | 70,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,20B | 1,17B | 997,24M | 858,15M | 749,43M |
| Total Liabilities | 433,81M | 408,42M | 345,00M | 373,59M | 296,98M |
| Shareholders' Equity | 476,43M | 488,93M | 476,19M | 315,79M | 295,61M |
| Total Debt | 425,74M | 295,23M | 258,59M | 295,34M | 223,08M |
| Cash & Equivalents | 35,57M | 41,36M | 152,83M | 31,59M | 28,57M |
| Current Assets | 139,99M | 137,58M | 233,38M | 111,27M | 95,17M |
| Current Liabilities | 139,04M | 116,28M | 102,19M | 85,49M | 83,48M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#497 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026